{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:36:38Z","timestamp":1793835398387,"version":"4.6.1"},"reference-count":30,"publisher":"American Chemical Society (ACS)","issue":"17","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81825020"],"award-info":[{"award-number":["81825020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82150208"],"award-info":[{"award-number":["82150208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82425104"],"award-info":[{"award-number":["82425104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3400504"],"award-info":[{"award-number":["2022YFC3400504"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018538","name":"National Ten Thousand Talent Program","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100018538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The EGFRC797S mutation is the main mechanism of acquired resistance to Osimertinib in NSCLC. There is an urgent need for small-molecule inhibitors to overcome Osimertinib-resistance. In this article, we developed a series of pteridin-7(8H)-one-derived inhibitors of EGFRL858R\/T790M\/C797S (EGFRLR\/TM\/CS) integrating direct interactions with the mutated Ser797 residue and the hydrophobic pocket encircled by the gatekeeper Met790 residue. Among them, M49 exhibited potent inhibitory activity against EGFRLR\/TM\/CS (IC50 = 18.94 nM) and showed great kinase selectivity (S(35) = 0.005). Pharmacokinetic studies revealed that orally dosed M49 at 10 mg\/kg resulted in a Cmax of 230.07 ng\/mL and oral bioavailability of 12.14%. Moreover, M49 demonstrated effective antitumor efficacy in BaF3-EGFRL858R\/T790M\/C797S xenograft model in comparison with Brigatinib (TGI = 73.53% vs 56.05%). In all, this study provided a novel EGFRLR\/TM\/CS inhibitor discovery strategy and a pteridin-7(8H)-one-based EGFRLR\/TM\/CS inhibitor which exhibited great potency and selectivity both in vitro and in vivo.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c01313","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T13:24:27Z","timestamp":1756387467000},"page":"18463-18490","source":"Crossref","is-referenced-by-count":4,"title":["Direct Ser797\nInteracted Pteridine-7(8\n                    <i>H<\/i>\n                    )-one Derivatives\nas Highly Selective and Orally Available\nEGFRL858R\/T790M\/C797S Inhibitors"],"prefix":"10.1021","volume":"68","author":[{"given":"Wenzhe","family":"Jiang","sequence":"first","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupei","family":"He","sequence":"additional","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Wang","sequence":"additional","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husheng","family":"Du","sequence":"additional","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dou","family":"Dou","sequence":"additional","affiliation":[{"name":"Hebei Agricultural University , , ,","place":["Baoding, China, 071001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Hu","sequence":"additional","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolin","family":"Hu","sequence":"additional","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buyao","family":"Hu","sequence":"additional","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Sha","sequence":"additional","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Mei","sequence":"additional","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjiang","family":"Zhao","sequence":"additional","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2270-1900","authenticated-orcid":true,"given":"Honglin","family":"Li","sequence":"additional","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]},{"name":"East China Normal University , , ,","place":["Shanghai, China, 200062"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqing","family":"Li","sequence":"additional","affiliation":[{"name":"Fudan University , , ,","place":["Shanghai, China, 200433"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4946-4722","authenticated-orcid":true,"given":"Yufang","family":"Xu","sequence":"additional","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-0758","authenticated-orcid":true,"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[{"name":"East China University of Science and Technology , , ,","place":["Shanghai, China, 200237"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"2026073102095536300_cit1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature11404","article-title":"The Cancer Genome Atlas Research Network. Comprehensive genomic characterization\nof squamous cell lung cancers","volume":"489","year":"2012","journal-title":"Nature"},{"key":"2026073102095536300_cit2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrc2088","article-title":"Epidermal growth\nfactor receptor mutations in lung cancer","volume":"7","author":"Sharma","year":"2007","journal-title":"Nat.\nRev. Cancer"},{"key":"2026073102095536300_cit3","doi-asserted-by":"publisher","first-page":"78985","DOI":"10.18632\/oncotarget.12587","article-title":"The prevalence\nof EGFR mutation in patients with non-small cell lung cancer: a systematic\nreview and meta-analysis","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"2026073102095536300_cit4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"2026073102095536300_cit5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small\ncell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"2026073102095536300_cit6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-pathol-011110-130206","article-title":"EGFR mutations and\nlung cancer","volume":"6","author":"da Cunha Santos","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"2026073102095536300_cit7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.lungcan.2019.09.019","article-title":"Resistance\nmechanisms to osimertinib in EGFR-mutated advanced non-small-cell\nlung cancer: A multicentric retrospective French study","volume":"137","author":"Mehlman","year":"2019","journal-title":"Lung Cancer"},{"issue":"11","key":"2026073102095536300_cit8","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.tips.2016.09.003","article-title":"EGFR as a Pharmacological Target\nin EGFR-Mutant Non-Small-Cell Lung\nCancer: Where Do We Stand Now?","volume":"37","author":"Ke","year":"2016","journal-title":"Trends Pharmacol.\nSci."},{"key":"2026073102095536300_cit9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.lungcan.2020.07.014","article-title":"Mechanisms\nof osimertinib resistance\nand emerging treatment options","volume":"147","author":"Schmid","year":"2020","journal-title":"Lung Cancer"},{"key":"2026073102095536300_cit10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s43018-021-00195-8","article-title":"Overcoming therapy\nresistance in EGFR-mutant lung cancer","volume":"2","author":"Passaro","year":"2021","journal-title":"Nat.\nCancer"},{"issue":"1","key":"2026073102095536300_cit11","doi-asserted-by":"publisher","first-page":"14768","DOI":"10.1038\/ncomms14768","article-title":"Brigatinib combined\nwith anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated\nnon-small-cell lung cancer","volume":"8","author":"Uchibori","year":"2017","journal-title":"Nat. Commun."},{"key":"2026073102095536300_cit12","doi-asserted-by":"publisher","first-page":"105583","DOI":"10.1016\/j.phrs.2021.105583","article-title":"EGFR mutation\nmediates\nresistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular\nmechanisms to clinical research","volume":"167","author":"Dong","year":"2021","journal-title":"Pharmacol.\nRes."},{"key":"2026073102095536300_cit13","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1158\/1078-0432.CCR-22-3901","article-title":"BBT-176, a Novel Fourth-Generation Tyrosine Kinase\nInhibitor for Osimertinib-Resistant EGFR Mutations in Non-Small Cell\nLung Cancer","volume":"29","author":"Lim","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"2026073102095536300_cit14","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1158\/1535-7163.MCT-20-0229","article-title":"CH7233163\nOvercomes\nOsimertinib-Resistant EGFR-Del19\/T790M\/C797S Mutation","volume":"19","author":"Kashima","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"2026073102095536300_cit15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ejmech.2017.04.079","article-title":"Discovery of a potent\ndual ALK and\nEGFR T790M inhibitor","volume":"136","author":"Jang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"2026073102095536300_cit16","doi-asserted-by":"publisher","first-page":"6840","DOI":"10.1021\/acs.jmedchem.2c00168","article-title":"Conformational\nConstrained 4-(1-Sulfonyl-3-indol)yl-2-phenylaminopyrimidine\nDerivatives as New Fourth-Generation Epidermal Growth Factor Receptor\nInhibitors Targeting T790M\/C797S Mutations","volume":"65","author":"Chen","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026073102095536300_cit17","doi-asserted-by":"publisher","first-page":"9662","DOI":"10.1021\/acs.jmedchem.2c00704","article-title":"Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing\nNext-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell\nLung Cancer","volume":"65","author":"Eno","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026073102095536300_cit18","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1021\/jacs.6b08536","article-title":"Broad-Spectrum Kinase\nProfiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes","volume":"139","author":"Zhao","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"2026073102095536300_cit19","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1158\/1078-0432.CCR-16-0569","article-title":"The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes\nMechanisms of Resistance to First- and Second-Generation ALK Inhibitors\nin Preclinical Models","volume":"22","author":"Zhang","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"2026073102095536300_cit20","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1021\/acs.jmedchem.0c00200","article-title":"Structural\nBasis for EGFR Mutant Inhibition by Trisubstituted Imidazole Inhibitors","volume":"63","author":"Heppner","year":"2020","journal-title":"J. Med. Chem."},{"issue":"4","key":"2026073102095536300_cit21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ejmech.2018.02.051","article-title":"Discovery of 2,4,6-trisubstitued\npyrido [d]pyrimidine\nderivatives as new EGFR-TKIs","volume":"2","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"2026073102095536300_cit22","doi-asserted-by":"publisher","first-page":"115865","DOI":"10.1016\/j.ejmech.2023.115865","article-title":"Modification\nof osimertinib to discover new potent EGFR(C797S)-TK inhibitors","volume":"261","author":"Xi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"2026073102095536300_cit23","doi-asserted-by":"publisher","first-page":"7634","DOI":"10.1002\/anie.201703389","article-title":"Discovery of EGF Receptor\nInhibitors That Are Selective for the d746\u2013750\/T790M\/C797S\nMutant through Structure-Based de Novo Design","volume":"56","author":"Park","year":"2017","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026073102095536300_cit24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nature17960","article-title":"Overcoming EGFR(T790M) and EGFR(C797S) resistance with\nmutant-selective allosteric inhibitors","volume":"534","author":"Jia","year":"2016","journal-title":"Nature"},{"key":"2026073102095536300_cit25","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1158\/2159-8290.CD-18-0903","article-title":"Single\nand Dual Targeting of Mutant EGFR with an Allosteric\nInhibitor","volume":"9","author":"To","year":"2019","journal-title":"Cancer Discovery"},{"key":"2026073102095536300_cit26","doi-asserted-by":"publisher","first-page":"7821","DOI":"10.1021\/jm401045n","article-title":"Discovery\nof pteridin-7(8H)-one-based irreversible inhibitors\ntargeting the epidermal growth factor receptor (EGFR) kinase T790M\/L858R\nmutant","volume":"56","author":"Zhou","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026073102095536300_cit27","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1021\/acs.jmedchem.1c02208","article-title":"Discovery of Pteridine-7(8H)-one\nDerivatives as Potent and Selective Inhibitors of Bruton\u2019s\nTyrosine Kinase (BTK)","volume":"65","author":"Dou","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026073102095536300_cit28","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.1021\/acs.jmedchem.9b00576","article-title":"Structure-Based\nDesign of 5-Methylpyrimidopyridone Derivatives as New Wild-Type Sparing\nInhibitors of the Epidermal Growth Factor Receptor Triple Mutant (EGFR(L858R\/T790M\/C797S))","volume":"62","author":"Shen","year":"2019","journal-title":"J. Med. Chem."},{"key":"2026073102095536300_cit29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1021\/acsmedchemlett.1c00555","article-title":"Optimization of Brigatinib as New Wild-Type Sparing Inhibitors of\nEGFR(T790M\/C797S) Mutants","volume":"13","author":"Li","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"2026073102095536300_cit30","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.1021\/acs.jmedchem.2c02015","article-title":"\u201cMagic Chloro\u201d:\nProfound Effects of the\nChlorine Atom in Drug Discovery","volume":"66","author":"Chiodi","year":"2023","journal-title":"J. Med. Chem."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c01313","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/17\/18463\/66294497\/acs.jmedchem.5c01313.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/17\/18463\/66294497\/acs.jmedchem.5c01313.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:10:03Z","timestamp":1785478203000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/17\/18463\/5234768\/Direct-Ser797-Interacted-Pteridine-7-8H-one"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":30,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,8,28]]},"published-print":{"date-parts":[[2025,9,11]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01313","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]}}}